Why the study?
Does screening for asymptomatic carotid artery stenosis improve outcomes in adults without a history of transient ischemic attack, stroke, or other neurologic signs or symptoms?
Systematic Review
Does screening for asymptomatic carotid artery stenosis improve outcomes in adults without a history of transient ischemic attack, stroke, or other neurologic signs or symptoms?
The USPSTF recommends against screening for asymptomatic carotid artery stenosis in the general adult population.
Avoid screening asymptomatic adults for carotid stenosis; reinforces consensus against low-value testing in primary prevention.
DESCRIPTION: Update of the 2007 U.S. Preventive Services Task Force (USPSTF) recommendation on screening for carotid artery stenosis. METHODS: The USPSTF commissioned a systematic review to synthesize the evidence on the accuracy of screening tests, externally validated risk-stratification tools, the benefits of treatment of asymptomatic carotid artery stenosis with carotid endarterectomy (CEA) or carotid angioplasty and stenting (CAAS), the benefits from medications added to current standard medical therapy, and the harms of screening and treatment with CEA or CAAS. POPULATION: This recommendation applies to adults without a history of transient ischemic attack, stroke, or other neurologic signs or symptoms. RECOMMENDATION: The USPSTF recommends against screening for asymptomatic carotid artery stenosis in the general adult population. (D recommendation).
No takes yet. Share an insight, caveat, or question.
Michael Lefevre (2014) conducted a systematic review in Asymptomatic carotid artery stenosis. Screening for asymptomatic carotid artery stenosis was evaluated. The USPSTF recommends against screening for asymptomatic carotid artery stenosis in the general adult population (D recommendation).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: